Indication

Anemia in Myelodysplastic Syndromes

1 clinical trial

1 product

Clinical trial

A Phase 1/2, Open-Label Clinical Study To Evaluate Safety And Efficacy Of TP-0184 To Treat Anemia When Administered To Adult Patients With IPSS-R Low Or Intermediate Risk Myelodysplastic Syndromes

Status: Terminated, Estimated PCD: 2021-04-27

Product